KEGG: bsu:BSU10300
STRING: 224308.Bsubs1_010100005716
The aprE Antibody is a polyclonal antibody raised against Subtilisin E (EC 3.4.21.62), a serine protease encoded by the aprE gene in Bacillus subtilis (strain 168). This antibody specifically recognizes the bacterial protease and is primarily used in microbiology research focused on Bacillus species . The commercially available antibodies are typically raised in rabbits using recombinant Bacillus subtilis aprE protein as the immunogen, resulting in recognition of multiple epitopes on the target protein . Researchers use this antibody to study protease expression, secretion mechanisms, and gene regulation in bacterial systems.
Based on the search results, aprE Antibody has been validated for several key applications:
These applications allow researchers to detect and quantify aprE protein expression and localization in various experimental contexts. The most robust data has been obtained through Western blotting and ELISA applications .
Proper validation of aprE Antibody is critical for ensuring experimental reliability and reproducibility. Based on current best practices in antibody validation, researchers should implement a multi-step validation process:
Specificity testing using wild-type cells alongside isogenic CRISPR knockout (KO) variants of the same cells, which provides the most rigorous validation methodology
Western blot analysis with positive controls (recombinant aprE protein) and negative controls (lysates from aprE knockout Bacillus strains) to confirm single-band detection at the expected molecular weight
Titration experiments to determine optimal working concentrations for each application
Cross-reactivity assessment with related bacterial proteases, particularly those with high sequence homology
While the optimal CRISPR KO-based validation approach provides the highest confidence, it carries significant costs (estimated >$5,000 per antibody), which may exceed the typical commercial value of antibody products . Therefore, researchers should at minimum perform Western blot validation with appropriate controls before proceeding with experimental applications.
According to product specifications, aprE Antibody should be stored at -20°C or -80°C upon receipt . To maintain antibody integrity over extended periods:
Avoid repeated freeze-thaw cycles which can cause antibody degradation and loss of binding activity
Upon receipt, create working aliquots in volumes appropriate for single-use experiments
Store in the provided buffer system, which typically contains 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative
For reconstituted lyophilized antibodies, equilibrate to room temperature before opening to prevent moisture condensation that could damage the product
Always centrifuge briefly before opening to ensure all liquid is at the bottom of the vial
Following these storage guidelines will help maintain antibody activity throughout your research timeline and improve experimental consistency.
When designing experiments with aprE Antibody, several controls should be included to ensure valid and interpretable results:
The commercially available aprE Antibodies are primarily polyclonal antibodies raised in rabbits , which recognize multiple epitopes on the aprE protein. This multi-epitope recognition provides advantages and limitations compared to potential monoclonal alternatives:
| Characteristic | Polyclonal aprE Antibody | Monoclonal Alternative |
|---|---|---|
| Epitope Recognition | Multiple epitopes | Single epitope |
| Sensitivity | Higher (cumulative signal from multiple epitopes) | Lower (signal from single epitope) |
| Specificity | Lower (potential cross-reactivity) | Higher (reduced cross-reactivity) |
| Batch-to-Batch Consistency | Lower | Higher |
| Resistance to Target Denaturation | Higher (some epitopes may remain intact) | Lower (epitope loss can eliminate signal) |
| Application Versatility | More versatile across applications | May perform well in specific applications only |
When working with samples where aprE is expressed at low levels, several optimization approaches can enhance detection sensitivity:
Signal amplification systems:
Utilize high-sensitivity ECL substrates for Western blotting
Employ biotin-streptavidin amplification for enhanced signal
Implement tyramide signal amplification for immunofluorescence applications
Sample enrichment techniques:
Concentrate proteins using immunoprecipitation with aprE Antibody
Perform subcellular fractionation to isolate compartments with higher aprE concentration
Apply TCA precipitation to concentrate secreted aprE from culture media
Detection system optimization:
Use secondary antibodies with higher enzyme:antibody ratios
Extend exposure times for Western blot imaging
Employ cooled CCD cameras for improved signal capture with lower background
Background reduction strategies:
Extend blocking time (overnight at 4°C) with 5% BSA
Increase washing duration and buffer volume
Pre-absorb diluted antibody with lysates from aprE-knockout bacteria
Combining these approaches can significantly improve the detection of low-abundance aprE protein while maintaining experimental specificity.
The aprE protein belongs to a family of bacterial serine proteases with structural similarities, raising concerns about potential cross-reactivity. To assess and minimize this issue:
Assessment strategies:
Perform Western blot analysis using lysates from:
Wild-type Bacillus subtilis
aprE knockout mutants
Related Bacillus species (B. licheniformis, B. amyloliquefaciens)
Other bacteria expressing similar proteases
Conduct peptide competition assays:
Pre-incubate aprE Antibody with excess purified aprE protein
Compare binding patterns with and without competition
Reduction in signal confirms specific binding to aprE epitopes
Minimization techniques:
Antibody dilution optimization:
Test a dilution series to identify concentration with optimal signal-to-noise ratio
Use highest dilution that provides adequate specific signal
Pre-absorption:
Incubate diluted antibody with lysates from bacteria lacking aprE
Remove antibodies that bind non-target proteins
Modified buffer conditions:
Increase salt concentration (250-300 mM NaCl) to reduce non-specific ionic interactions
Add 0.1% Tween-20 to reduce hydrophobic interactions
Blocking optimization:
Test different blocking agents (BSA, milk, commercial blockers)
Extend blocking time to enhance competition for non-specific binding sites
These strategies should be systematically evaluated to determine the optimal approach for each specific experimental context.
Effective sample preparation is critical for successful aprE Antibody detection. For Bacillus subtilis cultures, the following optimized protocol is recommended:
Protocol for intracellular aprE detection:
Harvest bacterial cells in mid to late log phase (OD600 ~0.8-1.2) when aprE expression typically reaches detectable levels
Wash cell pellet twice with ice-cold PBS to remove media components
Resuspend in lysis buffer containing:
50 mM Tris-HCl (pH 8.0)
150 mM NaCl
1 mM EDTA
1 mM PMSF (protease inhibitor)
Lysozyme (5 mg/ml)
Incubate at 37°C for 30 minutes for cell wall digestion
Complete lysis by sonication (5 cycles of 10 seconds on/30 seconds off) on ice
Clear lysate by centrifugation (15,000 × g, 15 minutes, 4°C)
Quantify protein concentration using Bradford or BCA assay
Prepare samples for SDS-PAGE by mixing with Laemmli buffer and heating at 95°C for 5 minutes
Protocol for secreted aprE detection:
Grow bacterial culture to desired phase
Remove cells by centrifugation (5,000 × g, 10 minutes)
Filter supernatant through 0.22 μm filter to remove remaining cells
Concentrate proteins by one of these methods:
TCA precipitation (add 100% TCA to 10% final concentration, incubate on ice 30 minutes)
Ultrafiltration using 10 kDa MWCO device
Resuspend precipitated proteins in appropriate buffer for downstream application
These protocols maximize protein recovery while minimizing degradation that could affect antibody recognition.
The aprE Antibody serves as a valuable tool for studying protein expression dynamics in Bacillus subtilis through several methodological approaches:
Time-course expression analysis:
Sample cultures at defined intervals throughout growth phases
Process samples consistently using the protocols described in 2.4
Perform Western blot analysis with aprE Antibody
Quantify band intensities using densitometry
Plot relative expression levels against time/growth phase
Comparative strain analysis:
Prepare lysates from different Bacillus subtilis strains or regulatory mutants
Analyze aprE expression using consistent Western blot or ELISA protocols
Normalize expression to total protein or housekeeping gene product
Identify strain-specific differences in expression patterns
Response to environmental stimuli:
Culture bacteria under varying conditions (pH, temperature, nutrient availability)
Quantify aprE expression changes in response to each condition
Correlate expression patterns with environmental parameters
Identify regulatory mechanisms through comparison with known stress-response systems
Subcellular localization dynamics:
Perform cellular fractionation to separate cytoplasmic, membrane, and extracellular fractions
Detect aprE in each fraction using the antibody
Monitor changes in distribution across fractions under different conditions
Assess secretion efficiency in wild-type versus secretory pathway mutants
These approaches provide complementary insights into the regulation, production, and processing of aprE protein in bacterial systems.
Multiplex detection using aprE Antibody in combination with other antibodies can provide valuable insights into protein co-expression and potential interactions. Several methodological approaches are available:
Dual immunofluorescence labeling:
Select primary antibodies raised in different host species (e.g., rabbit anti-aprE with mouse anti-regulatory proteins)
Use species-specific secondary antibodies conjugated to spectrally distinct fluorophores
Important considerations:
Ensure no spectral overlap between selected fluorophores
Validate each antibody individually before multiplexing
Include single-label controls to confirm specificity
Sequential immunoblotting:
After detecting aprE, strip the membrane using a mild stripping buffer:
15 mM glycine, 1% SDS, 1% Tween-20, pH 2.2 (10 minutes at room temperature)
Verify complete stripping with secondary antibody incubation
Reprobe with antibodies against other proteins of interest
Critical factors:
Validate that stripping does not remove target proteins
Optimize stripping conditions to maintain membrane integrity
Consider proteins of similar molecular weight that may be difficult to distinguish
Capillary-based automated Western systems:
Utilize systems like Jess or Wes (ProteinSimple) that allow multiplexing by size
Label aprE Antibody with one fluorophore and other antibodies with distinct fluorophores
Benefits include:
Higher reproducibility than traditional Western blotting
Reduced sample consumption
Automated quantification
Proximity ligation assay (PLA):
Combine aprE Antibody with antibodies against potential interaction partners
Use oligonucleotide-labeled secondary antibodies that generate amplifiable DNA only when in close proximity
Provides in situ detection of protein-protein interactions with high sensitivity
These methods require careful optimization and appropriate controls to ensure reliable multiplex detection of aprE alongside other proteins of interest.
The performance of aprE Antibody can vary significantly across different buffer systems, which is a critical consideration for experimental design. Systematic evaluation of the following parameters is recommended:
| Buffer Component | Optimal Range | Effects Outside Range | Recommended Optimization |
|---|---|---|---|
| pH | 7.0-8.0 | <6.0: Reduced binding >9.0: Increased non-specific binding | Test pH range 6.5-8.5 in 0.5 increments |
| Salt (NaCl) | 100-200 mM | <50 mM: Increased non-specific binding >300 mM: Reduced specific binding | Start at 150 mM; adjust ±50 mM based on results |
| Detergents | Tween-20: 0.05-0.1% Triton X-100: 0.1-0.5% | >0.5%: Possible epitope masking <0.01%: Insufficient blocking | Test multiple detergent types and concentrations |
| Blocking Proteins | BSA: 2-5% Milk: 3-5% | <1%: Insufficient blocking >10%: Potential epitope masking | Compare BSA, milk, and commercial blockers |
| Divalent Cations | 0-5 mM | >10 mM: Can affect protein conformation and antibody binding | Test addition of 1-5 mM CaCl₂ or MgCl₂ |
A systematic buffer optimization experiment should:
Start with standard TBS-T (25 mM Tris, 150 mM NaCl, 0.1% Tween-20, pH 7.4)
Modify one variable at a time
Quantify signal-to-noise ratio for each condition
Select conditions that maximize specific signal while minimizing background
This methodical approach will identify optimal buffer conditions for each specific application of aprE Antibody.
When investigating the subcellular localization of aprE protein in bacterial cells, several advanced imaging methodologies can be employed:
Super-resolution microscopy techniques:
Structured Illumination Microscopy (SIM): Achieves ~100 nm resolution through patterned illumination
Stimulated Emission Depletion (STED): Provides ~30-50 nm resolution using depletion laser
Single Molecule Localization Microscopy (PALM/STORM): Reaches ~10-20 nm resolution through sequential activation
Implementation protocol:
Use highly specific secondary antibodies conjugated to bright, photostable fluorophores
Mount samples with anti-fade reagents to minimize photobleaching
Include fiducial markers for drift correction during image acquisition
Optimize fixation to preserve cellular ultrastructure (e.g., 2% PFA + 0.1% glutaraldehyde)
Correlative Light and Electron Microscopy (CLEM):
Visualize aprE using fluorescence microscopy
Process same sample for electron microscopy
Correlate fluorescence signal with ultrastructural features
Critical considerations:
Use specialized sample preparation compatible with both imaging modalities
Include registration markers visible in both light and electron microscopy
Optimize fixation and embedding protocols to preserve antigenicity and ultrastructure
Expansion Microscopy:
Physically expand the sample through a swellable polymer
Achieve effective super-resolution with standard microscopes
Particularly useful for visualizing aprE distribution in densely packed bacterial cells
Protocol adaptation for bacterial cells:
Modify cell wall digestion steps for efficient expansion
Use bright, polymer-anchorable fluorophores
Calculate expansion factor using fiducial markers for accurate size determination
Cryo-fluorescence microscopy:
Rapidly freeze samples without fixation to preserve native state
Perform fluorescence imaging at cryogenic temperatures
Minimizes artifacts associated with chemical fixation
Technical requirements:
Specialized cryo-stage and environmental control
Fluorophores that maintain brightness at low temperatures
Rapid sample preparation to prevent ice crystal formation
These advanced imaging approaches provide complementary information about aprE localization with unprecedented spatial resolution and structural context.
The conformation-dependent binding properties of aprE Antibody have significant implications for experimental applications. Several methodological approaches can assess and validate specificity for native versus denatured conformations:
Parallel native and denaturing Western analysis:
Prepare identical samples under native (non-reducing, no SDS, no heating) and denaturing conditions
Run parallel native and SDS-PAGE gels
Transfer and probe with aprE Antibody
Compare binding patterns and signal intensities
Results interpretation:
Equal signal: Conformation-independent epitope recognition
Stronger signal in denatured samples: Recognition of buried epitopes
Stronger signal in native samples: Conformation-dependent epitope
Enzyme-linked immunosorbent assay (ELISA) variants:
Coat plates with native purified aprE protein
Compare with heat-denatured aprE protein (95°C, 10 minutes)
Detect with aprE Antibody using standard ELISA protocol
Measure relative binding affinity to each conformation
Immunoprecipitation efficiency comparison:
Perform parallel immunoprecipitations under native conditions and with denatured samples
Quantify pull-down efficiency by Western blot analysis of input, unbound, and bound fractions
Calculate percent recovery under each condition
Dot blot analysis with conformational treatments:
Spot identical amounts of aprE protein treated with:
Buffer only (native)
Heat denaturation (95°C, 5 minutes)
Chemical denaturation (6M guanidine HCl)
Mild reduction (1mM DTT)
Complete reduction (10mM DTT)
Probe with aprE Antibody and quantify signal intensities
These comparative approaches provide critical information about epitope accessibility and antibody binding characteristics that can guide experimental design and interpretation.
Computational approaches can significantly enhance the interpretation of experimental results obtained with aprE Antibody. Several methodological frameworks can be applied:
Epitope prediction and cross-reactivity assessment:
Generate 3D structural models of aprE and related bacterial proteases
Perform sequence alignment to identify conserved regions
Use epitope prediction algorithms to identify likely antibody binding sites
Cross-reference with experimentally observed cross-reactivity patterns
This approach helps:
Predict potential false positives in complex samples
Design blocking peptides for specificity confirmation
Interpret unexpected binding patterns
Signal quantification and normalization strategies:
Apply automated band detection and quantification algorithms
Implement background subtraction methods (rolling ball, local baseline)
Normalize signal to loading controls using various mathematical models:
Linear regression for standard curve generation
LOWESS smoothing for non-linear relationships
Housekeeping protein normalization with stability assessment
These approaches improve:
Reproducibility across experiments
Detection of subtle expression changes
Correction for technical variations
Machine learning classification of antibody binding patterns:
Train algorithms on datasets with known aprE expression profiles
Apply to new samples to identify canonical versus non-canonical binding patterns
Use ensemble methods to improve classification accuracy
Benefits include:
Automated identification of specific versus non-specific binding
Pattern recognition across multiple experiments
Reduced subjectivity in data interpretation
Molecular dynamics simulations of antibody-antigen interactions:
Model the 3D structure of aprE protein and antibody binding regions
Simulate physical interactions under various conditions
Predict effects of mutations, pH changes, or buffer compositions
Applications include:
Optimizing experimental conditions for maximum binding affinity
Understanding conformational epitopes
Predicting cross-reactivity with related proteins
Integration of these computational approaches with experimental data provides a more comprehensive understanding of aprE Antibody binding characteristics and enhances data interpretation in complex bacterial systems.